Last updated: 19 July 2019 at 5:54pm EST

Sudhakar V Shenoy Net Worth




The estimated Net Worth of Sudhakar V Shenoy is at least $39.3 mil dollars as of 19 April 2013. Sudhakar Shenoy owns over 105,000 units of IGC Pharma Inc stock worth over $39,323 and over the last 16 years Sudhakar sold IGC stock worth over $0.

Sudhakar Shenoy IGC stock SEC Form 4 insiders trading

Sudhakar has made over 1 trades of the IGC Pharma Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Sudhakar bought 105,000 units of IGC stock worth $39,323 on 19 April 2013.

The largest trade Sudhakar's ever made was buying 105,000 units of IGC Pharma Inc stock on 19 April 2013 worth over $39,323. On average, Sudhakar trades about 11,667 units every 0 days since 2009. As of 19 April 2013 Sudhakar still owns at least 105,000 units of IGC Pharma Inc stock.

You can see the complete history of Sudhakar Shenoy stock trades at the bottom of the page.



What's Sudhakar Shenoy's mailing address?

Sudhakar's mailing address filed with the SEC is PO BOX 60642, , POTOMAC, MD, 20859.

Insiders trading at IGC Pharma Inc

Over the last 17 years, insiders at IGC Pharma Inc have traded over $12,397,736 worth of IGC Pharma Inc stock and bought 1,543,722 units worth $473,972 . The most active insiders traders include Ram Mukunda, Steven Michael Oliveira y Zwirn & Co., L.P.Zwirn Dani.... On average, IGC Pharma Inc executives and independent directors trade stock every 143 days with the average trade being worth of $93,624. The most recent stock trade was executed by Ram Mukunda on 13 March 2024, trading 1,184,585 units of IGC stock currently worth $443,627.



What does IGC Pharma Inc do?

igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments



Complete history of Sudhakar Shenoy stock trades at IGC Pharma Inc

Persona
Trans.
Transacción
Precio total
Sudhakar V Shenoy
Director
Comprar $189,000
19 Apr 2013


IGC Pharma Inc executives and stock owners

IGC Pharma Inc executives and other stock owners filed with the SEC include: